Corrigendum to 'First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis': Annals of Oncology 2021; volume 32: 983-993.

Emens, L A; Adams, S; Barrios, C H; Diéras, V; Iwata, H; Loi, S; Rugo, H S; Schneeweiss, A; Winer, E P; Patel, S; Henschel, V; Swat, A; Kaul, M; Molinero, L; Patel, S; Chui, S Y; Schmid, P

Emens, L A; Adams, S; Barrios, C H; Diéras, V; Iwata, H; Loi, S; Rugo, H S; Schneeweiss, A; Winer, E P; Patel, S; Henschel, V; Swat, A; Kaul, M; Molinero, L; Patel, S; Chui, S Y; Schmid, P.

Afiliação

Emens LA; University of Pittsburgh Medical Center Hillman Cancer Center and Department of Medicine, Pittsburgh, USA. Electronic address: emensla@upmc.edu.
Adams S; Breast Cancer Center, and Department of Medicine, New York University Langone Health, Perlmutter Cancer Center, New York, USA.
Barrios CH; Oncology Clinics Group, Centro de Pesquisa Clínica, HSL, PUCRS, Porto Alegre, Brazil.
Diéras V; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.
Iwata H; Breast Cancer Oncology Department, Aichi Cancer Center Hospital, Nagoya, Japan.
Loi S; Translational Breast Cancer Genomics and Therapeutics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
Rugo HS; Department of Medicine, University of California San Francisco Comprehensive Cancer Center, San Francisco, USA.
Schneeweiss A; National Center for Tumor Diseases, University Hospital and German Cancer Research Center Heidelberg, Heidelberg, Germany.
Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
Patel S; Product Development Oncology, Genentech, Inc., South San Francisco, USA.
Henschel V; Product Development Data Science, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Swat A; Product Development Oncology, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Kaul M; Product Development Safety, Genentech, Inc., South San Francisco, USA.
Molinero L; Oncology Biomarker Development, Genentech, Inc., South San Francisco, USA.
Patel S; Product Development Data Sciences, Genentech, Inc., South San Francisco, USA.
Chui SY; Product Development Oncology, Genentech, Inc., South San Francisco, USA.
Schmid P; Department of Cancer Medicine, Barts Cancer Institute, Queen Mary University London, London, UK.

Ann Oncol ; 32(10): 1308, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34353668

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article